MoneyWorks4Me

Lupin - Quaterly Results

14 May 2025 Evaluate
The sales for the March 2025 quarter moved up 32.09% to Rs. 44856.70 millions as compared to Rs. 33958.80 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 236.22% to Rs. 12913.50  millions  from Rs. 3840.80 millions in previous same quarter.The company reported a good operating profit of 17949.20 millions compared to 7316.90 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 44856.70 33958.80 32.09 169675.00 146665.00 15.69 169675.00 146665.00 15.69
Other Income 487.90 313.40 55.68 1740.50 1067.30 63.08 1740.50 1067.30 63.08
PBIDT 17949.20 7316.90 145.31 56465.30 35657.90 58.35 56465.30 35657.90 58.35
Interest 338.50 134.90 150.93 845.00 563.50 49.96 845.00 563.50 49.96
PBDT 17610.70 7182.00 145.21 54848.10 35094.40 56.29 54848.10 35094.40 56.29
Depreciation 2079.80 2900.40 -28.29 6476.90 7247.50 -10.63 6476.90 7247.50 -10.63
PBT 15530.90 4281.60 262.74 48371.20 27846.90 73.70 48371.20 27846.90 73.70
TAX 2617.40 440.80 493.78 8641.60 4586.00 88.43 8641.60 4586.00 88.43
Deferred Tax -85.10 -249.80 -65.93 70.40 -254.50 -127.66 70.40 -254.50 -127.66
PAT 12913.50 3840.80 236.22 39729.60 23260.90 70.80 39729.60 23260.90 70.80
Equity 913.20 911.40 0.20 913.20 911.40 0.20 913.20 911.40 0.20
PBIDTM(%) 40.01 21.55 85.71 33.28 24.31 36.88 33.28 24.31 36.88
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..